Shares of Electra Therapeutics, Inc. (NASDAQ:ETRA - Get Free Report) have earned a consensus recommendation of "Buy" from the five analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a stron